Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
8.66
-0.72 (-7.68%)
At close: Dec 5, 2025, 4:00 PM EST
8.83
+0.17 (1.96%)
After-hours: Dec 5, 2025, 7:42 PM EST
Sutro Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 74 | 152 | 261 | 464 | 689 | 988 | |
| Market Cap Growth | -66.88% | -41.98% | -43.69% | -32.55% | -30.31% | 288.95% | |
| Enterprise Value | -76 | -212 | -55 | 193 | 453 | 731 | |
| Last Close Price | 8.66 | 18.40 | 42.90 | 80.80 | 148.80 | 217.10 | |
| PS Ratio | 0.69 | 2.44 | 1.70 | 6.85 | 11.13 | 23.12 | |
| PB Ratio | - | 3.40 | 1.75 | 2.14 | 2.73 | 2.98 | |
| P/TBV Ratio | - | 3.40 | 1.75 | 2.14 | 2.73 | 2.98 | |
| P/OCF Ratio | - | - | - | 130.85 | - | - | |
| EV/Sales Ratio | - | - | - | 2.85 | 7.32 | 17.11 | |
| Debt / Equity Ratio | -0.20 | 0.52 | 0.23 | 0.23 | 0.23 | 0.07 | |
| Asset Turnover | 0.32 | 0.14 | 0.35 | 0.18 | 0.17 | 0.16 | |
| Quick Ratio | 2.39 | 2.47 | 4.39 | 5.13 | 5.04 | 12.63 | |
| Current Ratio | 2.53 | 2.60 | 4.50 | 5.31 | 5.24 | 12.78 | |
| Return on Equity (ROE) | -1810.01% | -234.19% | -58.25% | -50.77% | -36.10% | -14.95% | |
| Return on Assets (ROA) | -25.80% | -34.74% | -12.72% | -21.54% | -16.74% | -16.13% | |
| Return on Capital (ROIC) | -256.77% | -118.73% | -24.76% | -27.91% | -18.48% | -19.13% | |
| Return on Capital Employed (ROCE) | -99.10% | -93.40% | -23.70% | -37.90% | -32.90% | -19.50% | |
| Earnings Yield | -294.01% | -149.92% | -40.84% | -25.67% | -15.33% | -3.25% | |
| FCF Yield | -305.33% | -128.28% | -44.34% | -0.93% | -14.09% | -7.58% | |
| Buyback Yield / Dilution | -17.26% | -27.70% | -18.57% | -10.02% | -41.59% | -41.88% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.